Skip to main content
OpenTrials

Clinical trial condition

Myositis Ossificans

Explore clinical trials studying Myositis Ossificans. Study availability and eligibility vary by location and protocol.

19 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Myositis Ossificans trial results

Recruiting

IL1 Inhibition in FOP

NCT06724562

Conditions
Fibrodysplasia Ossificans Progressiva (FOP), Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • UCSF San Francisco, California, United States
View Trial Details
Recruiting

A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

NCT06089616

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +2 more
Locations
  • The Regents of the University of California San Francisco, California, United States
  • The Trustees of the University of Pennsylvania, Office of Clinical Research-Legal Services, Perelman School of Medicine Philadelphia, Pennsylvania, United States
  • Edmonton Clinic Health Academy (ECHA)- University of Alberta Edmonton, Canada
  • Bone Research and Education Centre Oakville, Canada
View Trial Details
Recruiting

To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva

NCT05090891

Conditions
Fibrodysplasia Ossificans Progressiva (FOP), Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Children'S Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Penn Medicine - Perelman Center For Advanced Medicine Philadelphia, Pennsylvania, United States
  • Hospital Italiano de Buenos Aires Buenos Aires, Argentina
View all 24 locations
View Trial Details
Active, not recruiting

A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)

NCT05394116

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • University of California Los Angeles (UCLA) Medical Center Los Angeles, California, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Hospital Israelita Albert Einstein São Paulo, Brazil
View all 22 locations
View Trial Details
Active, not recruiting

A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

NCT06508021

Conditions
Fibrodysplasia Ossificans Progressiva, Foot Deformities, Hallux Valgus, +10 more
Locations
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Pennsylvania - Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.

NCT05027802

Conditions
Fibrodysplasia Ossificans Progressiva (FOP), Muscular Diseases, Musculoskeletal Diseases, +2 more
Locations
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Children's Hospital of Philidelphia Philadelphia, Pennsylvania, United States
  • The Perelman School of Medicine - The University of Pennsylvania Philadelphia, Pennsylvania, United States
View all 13 locations
View Trial Details
Completed

An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)

NCT02279095

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • University of California San Francisco, Division of Endocrinology and Metabolism San Francisco, California, United States
  • Mayo Clinic, Department of Medicine Rochester, Minnesota, United States
  • University of Pennsylvania, Center for FOP & Related Bone Disorders Philadelphia, Pennsylvania, United States
  • Hospital Italiano de Buenos Aires, Department of Pediatrics Buenos Aires, Argentina
View Trial Details

Related conditions